Bucci TJ, Howard PC, Tolleson WH, Laborde JB, and Hansen DK (1998). Renal effects of fumonisin mycotoxins in animals . Toxicol. Pathol. 26: 160-164.
2.
Davis MA, Chang SH, and Trump BF (1996). Differential sensitivity of normal and H-ras oncogene-transformed rat kidney epithelial cells to okadaic acid-induced changes. Toxicol. Appl. Pharmacol. 141: 93-101.
3.
Davis MA, Smith MW, Chang SH, and Trump BF (1994). Characterization of a renal epithelial cell model of apoptosis using okadaic acid and the NRK-52E cell line. Toxicol. Pathol. 22: 595-605.
4.
Kockx MM, Muhring J., Knaapen MWM, and de Meyer GRY (1998). RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis . Am. J. Pathol. 152: 885-888.
5.
Levin S. (1995). Commentary: A toxicologic pathologist's view of apoptosis or I used to call it necrobiosis, but now I'm singing the apoptosis blues. Toxicol. Pathol. 23: 533-539.
6.
Levin S. (1998). Toxicological highlights: Apoptosis, necrosis, or oncosis. What is your diagnosis? A report from the Cell Death Nomenclature Committee of the Society of Toxicologic Pathologists. Toxicol. Sci. 41: 155-156.
7.
Lincz LF (1998). Deciphering the apoptotic pathway: All roads lead to death. Immunol. Cell Biol. 76: 1-19.
8.
Merrill AH, Van Echten G., and Riley RT (1997). Sphingolipids: The enigmatic lipid class: Biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol . 142: 208-225.
9.
Mundle S. and Raza A. (1995). The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis. Lab. Invest. 72: 611-612.
10.
Sander EJ (1997). Methods for detecting apoptotic cells in tissues . Histol. Histopatlzol. 12: 1169-1177.
11.
Short BG, Zimmerman DM, and Schwartz LW (1997). Automated double labeling of proliferation and apoptosis in glutathione S-transferase-positive hepatocytes in rats. J. Histochem. Cytochem. 45: 1299-1305.
